The survey focuses on access-based pricing of medicinal products. It seeks to gather insights from all stakeholders on the price Tuesday September 30th the National Institute for Value and Technologies in Healthcare in collaboration with Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava presented the new HTA methodological guideline for Slovakia. Professor Tomáš Tesař, Department of Organisation and Management in Pharmacy at the Pharmaceutical Faculty of Comenius University in Bratislava and National Institute for Value and Technologies in Healthcare organized the seminar. Tesař is one of the participants in ASCERTAIN. The seminar was held at the Slovakian Ministry of Health and was opend by Minister of Health, Kamil Sasko.
Professor Eline Aas representing the ASCERTAIN project (Department of Health Management and Health Economics, University of Oslo, Norway) gave an overview of the ASCERTAIN projects where the is to develop open access models to improve access and affordability of innovative health technologies in Europe. The work in ASCERTAIN address several factors of relevance for the new HTA guidelines for Slovakia, where the work related to cost-effectiveness thresholds is of particular relevance.
Important reflections and contributions were provided by András Incze, Akceso Advisors, Switzerland, Professor Marcin Czech, Warsaw University of Technology Business School, Poland, Professor Zoltán Kaló, Center of Health Technology Assessment, Semmelweis University and Syreon Research Institute, Budapest, Hungary and Bertalan Németh, Syreon Research Institute and Katarína Fedorová, National Institute for Value and Technologies in Healthcare.